As of 28/09/2023

Fund Overview

This Fund has now closed

Want to keep updated about CBDX and our other products?

Subscribe for updates

Why Invest in CBDX Medical Cannabis ETF?

Risks

The Sub-Fund and the companies in which it invests may be subject to a higher degree of regulatory oversight and regulatory action, which may include a restriction on the types of companies that the Sub-Fund may invest in at any time

If a company becomes delisted from an exchange due to noncompliance with the rules and policies of the exchange, the Investment Manager will use reasonable endeavours to remove the company from the Sub-Fund's portfolio

The value of equities and equity-related securities can be affected by daily stock and currency market movements

Investors' capital is fully at risk and investors may not get back the amount originally invested

Exchange rate fluctuations could have a negative or positive effect on returns 6. Further risks are disclosed in the KIID and Prospectus

As of 28/09/2023

Listings & Codes

Exchange Ticker RIC SEDOL ISIN Valoren WKN CCY Listing Date
LSE CBDX LN CBDX.L BGSXSL9 IE00BG5J1M21 - - USD 22/01/2020
LSE CBDP LN CBDP.L BGSXQX7 IE00BG5J1M21 - - GBP 22/01/2020
Xetra CBSX GY CBSX.DE BJBL4D5 IE00BG5J1M21 - A2PPE8 EUR 14/01/2020
SIX CBDX SW CBDX.S BMYC3S4 IE00BG5J1M21 51899559 - CHF 02/06/2020

Registrations

Fund Overview
TickerCBDX
Base CurrencyUSD
Income TreatmentAccumulating
Inception Date09/01/2020
IndexMedical Cannabis and Wellness Equity Index
Number of Holdings0
Rebalance FrequencyQuarterly, last business day in February, May, August and November
TER80 bps
Net Asset ValuesAs of 28/09/2023
NAV$2.77
Net Assets of Fund8,683,555.20 (USD)
Shares Outstanding3,134,000
Issuer AUM$0
Structure
Replication MethodPhysical
DomicileIreland
Financial End Year31/03
Legal FormICAV
Legal And Tax Information
UCITS EligibleYes
ISA EligibleYes
SIPP EligibleYes
UK Fund Reporting Status
Key Service Providers
CustodianJ.P. Morgan SE - Dublin Branch
Portfolio ManagerVident Advisory LLC
Index Details
IndexMedical Cannabis and Wellness Equity Index
CurrencyUSD
Index ProviderSolactive
Index TickerMEDCAWEN
CBDX Performance 1M 3M 6M YTD 12M Since Inception
(09/01/2020)
The Medical Cannabis and Wellness UCITS ETF - Acc -14.23% -26.15% -35.36% -40.18% -42.36% -64.63%
Medical Cannabis and Wellness Equity Index -17.37% -24.12% -32.41% -37.58% -40.31% -63.35%
Source: Bloomberg. as of 30 September 2023.

Performance for the fund and the index is shown in USD. Fund performance is shown net of fees with income reinvested where applicable. Please be aware that fees have a detrimental impact on the performance of an ETP. Past performance is not an indicator for future results. If fund is less than 12 months old, YTD field will be calculated since inception.

Insights

NewsFebruary 2021

Video | The Medical Cannabis and Wellness ETF PM says GW Pharma deal validates pharmaceutical cannabinoids
Read More

NewsAugust 2020

HANetf Adopts New Settlement Model for 6 ETFs
Read More

NewsJuly 2020

Medical Cannabis | ESG Portfolios
Read More

Webinars

WebinarSeptember 2020

Medical Cannabis: Behind the Scenes and Introduction to the CBD Industry | 9th September 2020
Read More

WebinarSeptember 2021

Cannabis Capital Markets Forum 2021 | September 7th 2021
Read More

Press Releases

PressAugust 2022

HANetf taps into growing Spanish ETF demand, registering 19 ETFs
Read More

PressAugust 2022

Over 40% of HANetf’s UCITS ETFs have successful sister products in the US
Read More

PressMarch 2021

Europe’s first medical cannabis and carbon avoidance solutions themed ETFs to list on Vienna Stock Exchange
Read More

Sign up to receive your investor pack and email alerts

Related Content

Listings & Codes

Exchange Ticker RIC SEDOL ISIN Valoren WKN CCY Listing Date
LSE CBDX LN CBDX.L BGSXSL9 IE00BG5J1M21 - - USD 22/01/2020
LSE CBDP LN CBDP.L BGSXQX7 IE00BG5J1M21 - - GBP 22/01/2020
Xetra CBSX GY CBSX.DE BJBL4D5 IE00BG5J1M21 - A2PPE8 EUR 14/01/2020
SIX CBDX SW CBDX.S BMYC3S4 IE00BG5J1M21 51899559 - CHF 02/06/2020

CBDX ESG Rating

CBDX has been classified as an Article 6 investment under the EU Sustainable Finance Disclosure Regulation (SFDR).

Contact Us

Tell us how we can help